| POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
| UNI - EN REPORT No | 33 | / | 2019 | ||||||||
| Date of issue: | 2019-07-30 | ||||||||||
| Short name of the issuer | |||||||||||
| SOPHARMA AD | |||||||||||
| Subject | |||||||||||
| Q2 2019 Individual financial report of Sopharma AD | |||||||||||
| Official market - legal basis | |||||||||||
| art. 56. 1. 2 of Act on Public Offering. | |||||||||||
| Unofficial market - legal basis | |||||||||||
| Contents of the report: | |||||||||||
| Financial report according to IFRS as at 30 June 2019 Notes to the financial report as at 30 June 2019 Management report as at 30 June 2019 Insider information as at 30 June 2019 Additional information as at 30 June 2019 Financial report according to BFSC standards as at 30 June 2019 Annex 9 as at 30 June 2019 Declaration as at 30 June 2019 Notification - Main export markets gain speed in H1 2019 | |||||||||||
| Annexes | |||||||||||
| File | Description | ||||||||||
| 3JR_Financial_statements_Q2_2019_EN.rar | Q2 2019 Individual financial report of Sopharma AD | ||||||||||
| SOPHARMA AD | |||||||||||||
| (fullname of the issuer) | |||||||||||||
| SOPHARMA AD | Farmaceutyczny (far) | ||||||||||||
| (short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
| 1220 | Sofia | ||||||||||||
| (post code) | (city) | ||||||||||||
| IlienskoShosse | 16 | ||||||||||||
| (street) | (number) | ||||||||||||
| +359 2 813 42 00 | +359 2 936 02 86 | ||||||||||||
| (phone number) | (fax) | ||||||||||||
| (e-mail) | (web site) | ||||||||||||
| nd | |||||||||||||
| (NIP) | (REGON) | ||||||||||||
| SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
| Date | Name | Position / Function | Signature | ||
| 2019-07-30 | Ognian Donev | Executive director | |||
3JR_Financial_statements_Q2_2019_EN.rar
